Rhinoconjunctivitis Market Delivering High growth in the forecast period (2016 -2021)
The Global Rhinoconjunctivitis Market is
worth USD xx million in 2016 and estimated to grow at a CAGR ofxx.xx%, to reach
USD xx million by 2021. The global Rhinoconjunctivitis market is developing at
an exceptionally quick pace.
Browse
Market data tables and in-depth TOC of the Global Rhinoconjunctivitis Market to
2021 @ https://www.marketdataforecast.com/market-reports/global-rhinoconjunctivitis-market-5509/
Rhinoconjunctivitis refers to a medical
condition which is a combination of rhinitis and conjunctivitis and is one of
the most common allergic reactions worldwide. It is an inflammatory disorder
that affects nasal and conjunctival mucosa and is caused due to result of
hypersensitive immune response. Sneezing, watery mucus, itchy nose, and nasal
congestion, as well as conjunctivitis which include burning sensation, tears
and redness of eyes are some of the common symptoms of Rhinoconjunctivitis.
Poor sleep, irritability and fatigue are also some of the symptoms. According
to an article published in Journal of Allergy and Therapy, allergic rhinitis is
one of the most common reasons for hospital visits due to allergies.
Increasing awareness about
Rhinoconjunctivitis is expected to be the major growth factor during the
forecast period. Also improving medical infrastructure, increasing spending on
healthcare and increasing number of pharmaceutical players involved in R&D
in developing nations is expected to boost this industry.
Free
sample of the report is available @ https://www.marketdataforecast.com/market-reports/global-rhinoconjunctivitis-market-5509/request-sample
The global
Rhinoconjunctivitis market is segmented on the basis of Treatmentand region.
Based on treatmentthe market is segmented intoDecongestants, Mast-Cell
Stabilizers, Antihistamines, Nonsteroidal Anti-Inflammatory Drugs, and Intranasal
Corticosteroids. In case of frequent symptoms intra-nasal corticosteroids are
prescribed which include Avamys, Flonase, and Nasacort etc. If symptoms are
occasional Claritin, Reactine (cetirizine), Aerius, Allegra (fexofenadine) are
prescribed.
Geographically, the
Rhinoconjunctivitis market is segmented into North America, Europe,
Asia-Pacific, Latin America and Middle East and Africa. Asia Pacific had the
largest market share followed by North America. Asia Pacific was also the
fastest growing segment owing to increasing awareness and improving healthcare
infrastructure.
Inquire before buying @ https://www.marketdataforecast.com/market-reports/global-rhinoconjunctivitis-market-5509/inquire
Johnson & Johnson Inc.,
Merck & Co., Inc., GlaxoSmithKline, Sanofi Adiga Life Sciences Inc. are the
some key players in the global Rhinoconjunctivitismarket.
About Us:
Market Data Forecast is a firm working in the
area of market research and business intelligence. With rich experience in
research across various business domains, we cater to the needs of both
individual and corporate clients. Our analyst team comprises expert
professionals in market research, who with their collective knowledge and
skillset dedicatedly serve clients from various industries and regions.
Contact:
Abhishek Shukla
Sales Manager (International
Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Comments
Post a Comment